• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of patients with malignant lymphoma with Mini-BEAM reduces the yield of CD34+ peripheral blood stem cells.

作者信息

Weaver C H, Zhen B, Buckner C D

出版信息

Bone Marrow Transplant. 1998 Jun;21(11):1169-70. doi: 10.1038/sj.bmt.1701254.

DOI:10.1038/sj.bmt.1701254
PMID:9645585
Abstract
摘要

相似文献

1
Treatment of patients with malignant lymphoma with Mini-BEAM reduces the yield of CD34+ peripheral blood stem cells.采用Mini-BEAM方案治疗恶性淋巴瘤患者会降低CD34+外周血干细胞的采集量。
Bone Marrow Transplant. 1998 Jun;21(11):1169-70. doi: 10.1038/sj.bmt.1701254.
2
Combination chemotherapy with mitoguazon, ifosfamide, MTX, etoposide (MIME) and G-CSF can efficiently mobilize PBPC in patients with Hodgkin's and non-Hodgkin's lymphoma.米托胍腙、异环磷酰胺、甲氨蝶呤、依托泊苷（MIME）联合化疗及粒细胞集落刺激因子（G-CSF）能够有效动员霍奇金淋巴瘤和非霍奇金淋巴瘤患者的外周血祖细胞。
Bone Marrow Transplant. 1998 May;21(9):873-8. doi: 10.1038/sj.bmt.1701192.
3
Neutropenic infections in 100 patients with non-Hodgkin's lymphoma or Hodgkin's disease treated with high-dose BEAM chemotherapy and peripheral blood progenitor cell transplant: out-patient treatment is a viable option.100例接受大剂量BEAM化疗及外周血祖细胞移植治疗的非霍奇金淋巴瘤或霍奇金病患者的中性粒细胞减少性感染：门诊治疗是一种可行的选择。
Bone Marrow Transplant. 1999 Mar;23(6):599-605. doi: 10.1038/sj.bmt.1701610.
4
Autologous progenitor cell transplantation: prior exposure to stem cell-toxic drugs determines yield and engraftment of peripheral blood progenitor cell but not of bone marrow grafts.自体祖细胞移植：先前接触干细胞毒性药物决定外周血祖细胞的产量和植入，但不影响骨髓移植物。
Blood. 1995 Nov 15;86(10):3970-8.
5
[Autologous transplant with BEAM protocol in lymphoma].[淋巴瘤的BEAM方案自体移植]
Sangre (Barc). 1997 Apr;42 Suppl 1:46-9.
6
High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma.高剂量环磷酰胺、表柔比星、长春新碱和泼尼松（CEB）与大剂量化疗联合自体干细胞移植（BEAM）治疗淋巴瘤的比较
Bone Marrow Transplant. 2004 Oct;34(7):581-7. doi: 10.1038/sj.bmt.1704637.
7
Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.异环磷酰胺、依托泊苷、阿糖胞苷和地塞米松作为挽救治疗，随后进行大剂量环磷酰胺、美法仑和依托泊苷联合自体外周血干细胞移植用于复发或难治性淋巴瘤。
Eur J Haematol. 2007 Feb;78(2):93-101. doi: 10.1111/j.1600-0609.2006.00796.x.
8
Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.复发性化疗敏感型霍奇金淋巴瘤：传统强化化疗与高剂量化疗联合自体造血干细胞移植的随机对照试验
Lancet. 2002 Jun 15;359(9323):2065-71. doi: 10.1016/S0140-6736(02)08938-9.
9
A randomized trial of chemotherapy with carmustine, etoposide, cytarabine, and melphalan (BEAM) plus peripheral stem cell transplantation (PBSCT) vs single-agent high-dose chemotherapy followed by BEAM plus PBSCT in patients with relapsed Hodgkin's disease (HD-R2).一项针对复发霍奇金淋巴瘤（HD-R2）患者的随机试验，比较卡莫司汀、依托泊苷、阿糖胞苷和美法仑（BEAM）联合外周血干细胞移植（PBSCT）与单药大剂量化疗后序贯BEAM联合PBSCT的疗效。
Ann Hematol. 2002 Aug;81(8):424-9. doi: 10.1007/s00277-002-0495-y. Epub 2002 Aug 15.
10
Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (>/=60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol.外周血干细胞移植支持的大剂量化疗在老年（≥60岁）非霍奇金淋巴瘤患者中的可行性和毒性：与按照相同方案治疗的60岁以下患者的比较
Bone Marrow Transplant. 2000 Oct;26(7):737-41. doi: 10.1038/sj.bmt.1702577.

引用本文的文献

1
Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin's lymphoma with an emphasis on targeted therapies and transplantation strategies.复发/难治性霍奇金淋巴瘤的病理生理学与治疗进展，重点关注靶向治疗和移植策略
Blood Lymphat Cancer. 2017;7:37-52. doi: 10.2147/BLCTT.S105458. Epub 2017 May 9.
2
High-dose chemotherapy followed by autologous stem cell transplantation for patients with relapsed/refractory Hodgkin lymphoma.复发/难治性霍奇金淋巴瘤患者接受大剂量化疗后进行自体干细胞移植。
Cochrane Database Syst Rev. 2013 Jun 20;2013(6):CD009411. doi: 10.1002/14651858.CD009411.pub2.
3
ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 g m(-2) and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients.
对于预处理的淋巴瘤患者，ESHAP方案联合粒细胞集落刺激因子（G-CSF）是一种比环磷酰胺1.5 g/m²联合G-CSF更优的造血干细胞动员方案：78例患者的配对分析
Br J Cancer. 2000 Jan;82(2):278-82. doi: 10.1054/bjoc.1999.0915.